Macromolecular prodrugs X. Kinetics of fenoprofen release from PHEA-fenoprofen conjugate

被引:16
作者
van der Merwe, T
Boneschans, B
Zorc, B
Breytenbach, J
Zovko, M
机构
[1] Ctr Qual Assurance Med, ZA-2520 Potchefstroom, South Africa
[2] Potchefstroom Univ Christian Higher Educ, Dept Pharmaceut Chem, ZA-2520 Potchefstroom, South Africa
[3] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
关键词
fenoprofen; polymer-drug conjugate; poly[alpha; beta-(N-2-hydroxyethyl-DL-aspartamide); kinetic study; HPLC;
D O I
10.1016/S0378-5173(02)00197-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The kinetics of fenoprofen release from poly[alpha,beta-(N-2-hydroxyethyl-DL-aspartamide)]-fenoprofen conjugate (PHEA-Fen) in aqueous buffer solutions (pH 10 and 1.1). simulated gastric (SGF) and intestinal fluids (SIF) was studied. In borate buffer pH 10, the following rate constants were obtained: k = 0.2659 (t = 60 degreesC) and k = 0.0177 h (-1) (t = 37 degreesC) and in glycine buffer solution pH 1.1 k = 0.0036 h (-1). In SGF and SIF fenoprofen release did not occur in significant extend within 12 h. The hydrolysis of the ester bond between the polymeric carrier and fenoprofen followed the pseudo first-order kinetics, with activation energy indicative for the breakage of a sigma bond (E-a = 100.6 kJ mol (-1)) The concentration of the released fenoprofen was determined by high performance liquid chromatography (HPLC). (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 12 条
[1]   SYNTHESIS, CONTROLLED-RELEASE PROPERTIES AND ANTITUMOR-ACTIVITY OF ALGINATE-CIS-ACONITYL-DAUNOMYCIN CONJUGATES [J].
ALSHAMKHANI, A ;
DUNCAN, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) :107-119
[2]  
Boneschans Barend, 2002, Acta Pharmaceutica (Zagreb), V52, P37
[3]  
Duncan R, 1996, STP PHARMA SCI, V6, P237
[4]   Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1) [J].
Duncan, R ;
Coatsworth, JK ;
Burtles, S .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (02) :93-104
[5]  
GIAMMONA G, 1995, J CONTROL RELEASE, V33, P261, DOI 10.1016/0168-3659(94)00091-8
[6]   Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies [J].
Giammona, G ;
Cavallaro, G ;
Fontana, G ;
Pitarresi, G ;
Carlisi, B .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :321-331
[7]   Macromolecular prodrugs. VIII. Synthesis of polymer-gemfibrozil conjugates [J].
Lovrek, M ;
Zorc, B ;
Boneschans, B ;
Butula, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 200 (01) :59-66
[8]  
United States Pharmacopoeia Convention, 2000, US PHARM C, P2235
[9]  
*US PHARM CONV INC, 2000, US PHARM 24 S1, P2697
[10]  
Vasey PA, 1999, CLIN CANCER RES, V5, P83